BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsieh MH, Lu HJ, Lin CW, Lee CY, Yang SJ, Wu PH, Chen MK, Yang SF. Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer. J Pers Med 2021;11:348. [PMID: 33925911 DOI: 10.3390/jpm11050348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Hsieh MH, Wu YL, Tsao TC, Huang YW, Lin JC, Lee CY, Hsieh MJ, Yang SF. Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients. Int J Environ Res Public Health 2022;19:9971. [PMID: 36011604 DOI: 10.3390/ijerph19169971] [Reference Citation Analysis]
2 Hou Y, Zhou M, Li Y, Tian T, Sun X, Chen M, Xu W, Lu M. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway. Mol Carcinog 2022. [PMID: 35687049 DOI: 10.1002/mc.23422] [Reference Citation Analysis]
3 Kaur J, Salehen N, Norazit A, Rahman AA, Murad NAA, Rahman NMANA, Ibrahim K. Tumor Suppressive Effects of GAS5 in Cancer Cells. ncRNA 2022;8:39. [DOI: 10.3390/ncrna8030039] [Reference Citation Analysis]
4 Lee C, Yang Y, Kornelius E, Huang C, Hsu M, Lee C, Peng S, Yang S. Association of Long Non-Coding RNA Growth Arrest-Specific 5 Genetic Variants with Diabetic Retinopathy. Genes 2022;13:584. [DOI: 10.3390/genes13040584] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee SJ. Advances in Personalized Medicines along with Functional Genomics and Pharmacogenomics. J Pers Med 2021;11:941. [PMID: 34683082 DOI: 10.3390/jpm11100941] [Reference Citation Analysis]